Unknown

Dataset Information

0

New insights into the design of inhibitors of human S-adenosylmethionine decarboxylase: studies of adenine C8 substitution in structural analogues of S-adenosylmethionine.


ABSTRACT: S-adenosylmethionine decarboxylase (AdoMetDC) is a critical enzyme in the polyamine biosynthetic pathway and depends on a pyruvoyl group for the decarboxylation process. The crystal structures of the enzyme with various inhibitors at the active site have shown that the adenine base of the ligands adopts an unusual syn conformation when bound to the enzyme. To determine whether compounds that favor the syn conformation in solution would be more potent AdoMetDC inhibitors, several series of AdoMet substrate analogues with a variety of substituents at the 8-position of adenine were synthesized and analyzed for their ability to inhibit hAdoMetDC. The biochemical analysis indicated that an 8-methyl substituent resulted in more potent inhibitors, yet most other 8-substitutions provided no benefit over the parent compound. To understand these results, we used computational modeling and X-ray crystallography to study C(8)-substituted adenine analogues bound in the active site.

SUBMITTER: McCloskey DE 

PROVIDER: S-EPMC2652407 | biostudies-literature | 2009 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

New insights into the design of inhibitors of human S-adenosylmethionine decarboxylase: studies of adenine C8 substitution in structural analogues of S-adenosylmethionine.

McCloskey Diane E DE   Bale Shridhar S   Secrist John A JA   Tiwari Anita A   Moss Thomas H TH   Valiyaveettil Jacob J   Brooks Wesley H WH   Guida Wayne C WC   Pegg Anthony E AE   Ealick Steven E SE  

Journal of medicinal chemistry 20090301 5


S-adenosylmethionine decarboxylase (AdoMetDC) is a critical enzyme in the polyamine biosynthetic pathway and depends on a pyruvoyl group for the decarboxylation process. The crystal structures of the enzyme with various inhibitors at the active site have shown that the adenine base of the ligands adopts an unusual syn conformation when bound to the enzyme. To determine whether compounds that favor the syn conformation in solution would be more potent AdoMetDC inhibitors, several series of AdoMet  ...[more]

Similar Datasets

| S-EPMC5965259 | biostudies-literature
| S-EPMC2815669 | biostudies-literature
| S-EPMC2681509 | biostudies-literature
| S-EPMC1135037 | biostudies-other
| S-EPMC3267017 | biostudies-literature
| S-EPMC2533785 | biostudies-literature
| S-EPMC2847442 | biostudies-literature
| S-EPMC1152153 | biostudies-other
| S-EPMC4530663 | biostudies-literature
| S-EPMC3499050 | biostudies-literature